Thursday, AstraZeneca Plc (NASDAQ:AZN) raised its annualized dividend for 2024 by $0.20 to $3.10 per share, underlining the company’s confidence in its performance and cash generation.
The company said the 7% increase takes into account other capital allocation priorities and previously announced acquisitions and business development.
Michel Demaré, Chair, AstraZeneca, said: “This uplift is in line with our progressive dividend policy, which remains unchanged, and reflects the continuing strength of AstraZeneca’s investment proposition for shareholders.”
Reuters noted the shareholders are gearing up to vote on a proposal during the annual ...